Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2026-02-28 @ 11:15 AM
Study NCT ID:
NCT00577668
Status:
WITHDRAWN
Last Update Posted:
2011-05-03
First Post:
2007-12-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)
Sponsor:
University of Arkansas
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2007-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mauricio Pineda-Roman, MD
Old Organization:
University of Arkansas for Medical Sciences